Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Noronha

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 15, 2019
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose EscalationV Murthy, P Gupta, K Baruah, et al.
Indian Journal of Cancer|March 1, 2017
Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteriaA Joshi, A Ramaswamy, V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 2, 2024
Neoadjuvant Chemotherapy in Locally Advanced Sinonasal Teratocarcinosarcoma a Rare Malignancy: An Audit From an Academic Tertiary Care Centre in IndiaZ Peelay, S Saha, V Patil, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2015
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?S Kane, V M Patil, A Joshi, et al.
Indian Journal of Cancer|December 5, 2017
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patientsS Zanwar, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2018
Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck CancerV M Patil, V Noronha, A Joshi, et al.
Indian Journal of Cancer|May 10, 2017
Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysisS Zanwar, A Joshi, V Noronha, et al.
Indian Journal of Cancer|February 5, 2016
Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practiceP Kumar, J Bajpai, N Shetty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2021
Impact of Adjuvant Treatment in pN3 Penile CancerP Khurud, R Krishnatry, T Telkhade, et al.
Indian Journal of Cancer|May 6, 2016
Practical recommendation for rash and diarrhea management in Indian patients treated with tyrosine kinase inhibitors for the treatment of non-small cell lung cancerP Parikh, K Prabhash, R Naik, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 15, 2019
Adaptive Radiotherapy for Carcinoma of the Urinary Bladder: Long-term Outcomes With Dose EscalationV Murthy, P Gupta, K Baruah, et al.
Indian Journal of Cancer|March 1, 2017
Efficacy and safety of sorafenib in advanced renal cell cancer and validation of Heng criteriaA Joshi, A Ramaswamy, V Noronha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 2, 2024
Neoadjuvant Chemotherapy in Locally Advanced Sinonasal Teratocarcinosarcoma a Rare Malignancy: An Audit From an Academic Tertiary Care Centre in IndiaZ Peelay, S Saha, V Patil, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 29, 2015
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?S Kane, V M Patil, A Joshi, et al.
Indian Journal of Cancer|December 5, 2017
Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patientsS Zanwar, V Noronha, A Joshi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 24, 2018
Influence of Hypothyroidism After Chemoradiation on Outcomes in Head and Neck CancerV M Patil, V Noronha, A Joshi, et al.
Indian Journal of Cancer|May 10, 2017
Patterns of care and outcomes for second-line targeted therapy in metastatic renal cell carcinomas: A registry based analysisS Zanwar, A Joshi, V Noronha, et al.
Indian Journal of Cancer|February 5, 2016
Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practiceP Kumar, J Bajpai, N Shetty, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2021
Impact of Adjuvant Treatment in pN3 Penile CancerP Khurud, R Krishnatry, T Telkhade, et al.
Indian Journal of Cancer|May 6, 2016
Practical recommendation for rash and diarrhea management in Indian patients treated with tyrosine kinase inhibitors for the treatment of non-small cell lung cancerP Parikh, K Prabhash, R Naik, et al.
Pageof 11